Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cure Latam is a Colombian healthcare and medical technology company focused on supplying innovative medical devices and related service programs for chronic, catastrophic, and high-impact diseases. Its commercial focus appears to center on wound care, early breast lesion detection, otorhinolaryngology/audiology, and bone/tissue regeneration solutions. The company markets products such as Natrox, Pretiva, Endoform, Myriad Matrix, and Strubone, and complements these technologies with patient support and clinical follow-up programs. Cure Latam operates primarily in Colombia and positions itself as a provider of applied health innovation rather than a drug-development biotech company. Overall, it looks more like a commercial medtech and healthcare solutions company than a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cure Latam.